Rankings
▼
Calendar
TLSI Q1 2021 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
TLSI
TriSalus Life Sciences, Inc.
$175M
Q1 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$307,992
Net Income
-$372,034
EPS (Diluted)
$-0.01
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$205,848
Free Cash Flow
-$205,850
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$252M
Total Liabilities
$24M
Stockholders' Equity
$228M
Cash & Equivalents
$1M
← FY 2021
All Quarters
Q2 2021 →
